Paper26314532
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.
Généreux P and 18 others. J Am Coll Cardiol, 2015. Cited by 386 papers, by iCite.
Cite this record
ConductScience Library. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. Papers, record 26314532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26314532
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Artery Disease | Major topic |
| Drug-Eluting Stents | Major topic |
| Percutaneous Coronary Intervention | Major topic |
| Platelet Aggregation Inhibitors | Major topic |
| Postoperative Hemorrhage | Major topic |
| Adult | |
| Aged | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Multivariate Analysis | |
| Patient Discharge | |
| Platelet Aggregation | |
| Postoperative Care | |
| Predictive Value of Tests | |
| Proportional Hazards Models | |
| Prospective Studies | |
| Radiography | |
| Risk Assessment | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00638794 | Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 26314533 | The Shifting Pendulum for DAPT After PCI: Balancing Long-Term Risks for Bleeding and Thrombosis. | https://conductscience.org/library/papers/26314533 |
Source PubMed
Cited by162
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 386 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42911529 | The FIBR-CMR score: a novel risk model integrating fibrinogen and cardiac magnetic resonance for major adverse events after STEMI. | Radiol Med | 2026 | https://conductscience.org/library/papers/42911529 | PubMed |
| 42856937 | Limited Impact of High Bleeding Risk Calculation and Peri-Procedural Discussion on Dual-Antiplatelet Therapy Duration and Clinical Outcomes After Percutaneous Coronary Intervention. | Circ Rep | 2026 | https://conductscience.org/library/papers/42856937 | PubMed |
| 42795913 | Gastrointestinal Bleeding Is Associated with Worse In-Hospital Outcomes in Patients with ST-Segment Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample. | J Clin Med | 2026 | https://conductscience.org/library/papers/42795913 | PubMed |
| 42534206 | Long-Term Antithrombotic Therapy After Percutaneous Coronary Intervention: Secondary Prevention Beyond One Year. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42534206 | PubMed |
| 42389288 | Association of blood-activating commercial Chinese polyherbal preparation with clinical outcomes in older patients with ischemic cardiovascular or cerebrovascular diseases: a real-world cohort study. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42389288 | PubMed |
| 41783931 | Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/41783931 | PubMed |
| 41710573 | Development and External Validation of a Nomogram for Predicting Upper Gastrointestinal Bleeding in Patients After Percutaneous Coronary Intervention: A Retrospective Multicenter Cohort Study. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/41710573 | PubMed |
| 41709119 | The Prognostic Impact of Multiple Adverse Events on Long-Term Mortality Following Acute Myocardial Infarction. | Catheter Cardiovasc Interv | 2026 | https://conductscience.org/library/papers/41709119 | PubMed |
| 41682970 | LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682970 | PubMed |
| 41554563 | Clinical Outcomes of Tegoprazan Versus Proton Pump Inhibitors in Patients Receiving Antiplatelet Therapy After Percutaneous Coronary Intervention: A Retrospective, Observational Study. | Korean J Helicobacter Up Gastrointest Res | 2026 | https://conductscience.org/library/papers/41554563 | PubMed |
| 41509615 | Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/41509615 | PubMed |
| 41420206 | The impact of heart failure and bleeding risk on clinical outcomes in patients after percutaneous coronary intervention. | BMC Cardiovasc Disord | 2025 | https://conductscience.org/library/papers/41420206 | PubMed |
| 41307518 | Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy. | JACC Asia | 2026 | https://conductscience.org/library/papers/41307518 | PubMed |
| 41276650 | Association between the modified Japanese Version of High Bleeding Risk scores and clinical outcomes in Japanese patients with lower extremity artery disease undergoing endovascular treatment. | Heart Vessels | 2026 | https://conductscience.org/library/papers/41276650 | PubMed |
| 41081254 | Associations of Thrombotic and Bleeding Risks With Plaque Morphology. | Circ Rep | 2025 | https://conductscience.org/library/papers/41081254 | PubMed |
| 40944090 | Antiplatelet Therapy in Atrial Fibrillation Patients on Direct Oral Anticoagulants Undergoing Percutaneous Coronary Intervention: Which and How. | J Clin Med | 2025 | https://conductscience.org/library/papers/40944090 | PubMed |
| 40808251 | Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Large Vessel Coronary Artery Disease. | Catheter Cardiovasc Interv | 2025 | https://conductscience.org/library/papers/40808251 | PubMed |
| 40802193 | Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial. | JAMA Cardiol | 2025 | https://conductscience.org/library/papers/40802193 | PubMed |
| 40634660 | Local Infusing Antiplatelet Microspheres to Prevent Thrombosis Post-PCI: a Feasibility Study in Rabbit Aorta. | Mol Imaging Biol | 2025 | https://conductscience.org/library/papers/40634660 | PubMed |
| 40461183 | Dual impact of anaemia and chronic kidney disease on postpercutaneous coronary intervention outcomes: insights from the Japanese nationwide registry. | Open Heart | 2025 | https://conductscience.org/library/papers/40461183 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26314532
GET https://conductscience.org/api/papers/v1/26314532/cited_by?page=2